HLB Group Chairman Jin Yang-gon has reaffirmed his commitment to management responsibility by additionally purchasing shares of HLB Life Science.

According to a regulatory filing by HLB Life Science on the 17th, Inside Director Jin Yang-gon recently purchased 14,000 common shares of the company on the open market over two days. Specifically, he acquired 10,000 shares at 2,194 won per share on the 15th, and 4,000 shares at 2,267 won per share on the 16th.

With this latest purchase, Chairman Jin's total holdings increased from 719,430 shares to 733,430 shares. His stake also rose by 0.05 percentage points (p), from 2.20% to 2.25%. HLB Life Science currently has a total of 32,554,286 issued shares.

This additional share purchase comes at a time when HLB Life Science's stock price has been exhibiting volatility, and is interpreted as evidence of the largest shareholder's confidence in the company's future corporate value and growth potential. The market assesses that Chairman Jin's successive share purchases, made while overseeing HLB Group's overall management and serving as an inside director of HLB Life Science, will serve as a positive signal for enhancing shareholder value and strengthening responsible management.